Concord Biotech Financials

NSE: CONCORDBIO | BSE: 543960

₹554.80

up-down-arrow ₹-26.20 (-4.51%)

As on 17-Nov-2026IST

Market cap

info icon

₹11,617 Cr

Revenue (TTM)

info icon

₹1,170 Cr

P/E Ratio

info icon

41.1

P/B Ratio

info icon

5.6

Div. Yield

info icon

0.7 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
1,170.41
1,054.89
1,200.09
1,016.94
853.17
712.93
Total Income
1,218.73
1,107.25
1,244.53
1,050.72
888.48
736.35
Total Expenditure
766.14
686.95
693.24
584.75
504.59
439.01
EBITDA
404.27
367.94
506.84
432.19
348.58
273.93
Depreciation
74.77
74.46
54.37
53.59
54.03
50.05
EBIT
329.50
293.48
452.47
378.60
294.55
223.88
Interest
0.24
0.82
1.04
3.18
9.80
6.14
Other Income
48.32
52.36
44.45
33.78
35.31
23.42
Exceptional Items
-3.28
-3.28
--
--
--
--
Profit before Tax
374.31
344.65
494.55
412.57
322.01
237.52
Provision for Tax
94.68
85.42
122.91
104.46
81.93
62.59
Profit after Tax
279.64
259.23
371.64
308.10
240.09
174.93
Minority Interest
3.07
1.68
--
--
--
--
Share of Associate
-0.26
--
--
--
--
--
Consolidated Profit
282.45
260.91
371.64
308.10
240.09
174.93

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
2,075.76
2,017.06
1,812.72
1,526.65
1,290.00
1,103.22
Minority Interest
3.07
-1.92
--
--
--
--
Non-Current Liabilities
53.38
47.58
37.47
31.91
32.14
54.40
Current Liabilities
201.71
169.08
184.06
142.16
191.84
344.24
Total Liabilities
2,326.97
2,231.79
2,034.25
1,700.71
1,513.98
1,501.87

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
980.16
981.68
899.01
804.48
786.28
869.20
Current Assets
1,290.68
1,250.11
1,135.24
896.23
727.70
632.67
Total Assets
2,326.97
2,231.79
2,034.25
1,700.71
1,513.98
1,501.87
Total Debt*
--
--
0.38
6.23
31.24
60.59
Net Current Assets
1,088.97
1,081.03
951.18
754.08
535.86
288.42
Contingent Liabilities
--
3.76
3.91
14.31
14.31
13.32

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
266.88
244.52
265.47
246.00
207.48
Cash Flow from Investing Activities
--
-142.72
-159.99
-154.61
-157.95
-111.79
Cash from Financing Activities
--
-112.88
-98.77
-99.21
-85.22
-100.16
Net Cash Inflow / Outflow
--
11.28
-14.24
11.64
2.83
-4.48

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
27.23
12.47
17.76
14.73
11.47
8.36
Cash EPS (₹) info
13.50
15.95
20.36
17.29
14.06
10.75
Adjusted Book Value (₹) info
99.71
96.40
86.64
72.96
61.65
52.72
Dividend per Share (₹) info
0.68
3.78
5.35
4.38
3.42
2.33
Cash Flow per Share (₹) info
--
25.51
23.37
25.38
23.51
218.14
Free Cash Flow per Share (₹) info
--
21.47
13.77
18.62
9.25
49.86

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
18.04
29.62
29.13
26.70
21.66
ROE (%) info
13.92
13.54
22.26
21.88
20.06
16.64
ROA (%) info
12.86
12.15
19.90
19.17
15.92
12.43
EBIT Margin (%) info
28.15
27.82
37.70
37.23
34.52
31.40
Net Margin (%) info
22.94
23.41
29.86
29.32
27.02
23.76
Cash Profit Margin (%) info
--
31.63
35.50
35.57
34.47
30.99

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
4.02
-12.10
18.01
19.20
19.67
15.56
EBIT Growth (%) info
-11.95
-35.14
19.51
28.54
31.57
-25.48
Net Profit Growth (%) info
-12.06
-30.25
20.62
28.33
37.25
-25.53
EPS Growth (%) info
-12.81
-29.80
20.62
28.33
37.25
-25.51
Book Value Growth (%) info
--
11.27
18.74
18.34
16.93
10.39

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
41.13
40.73
47.19
51.68
--
--
Price / Book Value info
5.57
5.27
9.67
10.43
--
--
Dividend Yield (%) info
0.68
0.74
0.64
0.57
--
--
EV/EBITDA info
25.65
25.25
31.81
34.08
0.00
-0.06
Close Price (₹) info
686.80
509.20
840.30
760.40
--
--
High Price (₹) info
833.80
1,075.20
1,332.00
804.10
--
--
Low Price (₹) info
493.50
495.00
663.45
370.50
--
--
Market Cap (₹ Cr) info
11,616.58
10,627.92
17,537.35
15,922.01
--
--

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
--
--
0.00
0.00
0.02
0.05
Short term debt to equity ratio info
--
--
0.00
--
--
0.00
Current Ratio info
6.40
7.39
6.17
6.30
3.79
1.84
Quick Ratio info
4.43
5.46
4.87
4.84
2.69
1.27
Interest Coverage info
1,593.82
419.57
475.76
130.57
33.85
39.72

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
35.24
43.63
43.47
34.38
32.09
32.57
Asset Turnover info
0.54
0.49
0.64
0.63
0.57
0.52
Receivable days info
--
169.86
132.49
111.87
108.22
102.99
Inventory Days info
--
97.92
68.07
75.42
87.15
87.67
Payable days info
--
159.68
123.94
149.88
179.16
144.10
Cash Conversion Cycle info
--
108.11
76.63
37.41
16.22
46.55
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month